process, provide enormous economic advantages to patients and the health care system, with estimates of $338 billion in savings annually from the availability of these medications. Generic drugs ...

and streamlining the process by waiving the requirement that a generic and brand manufacturer share a single system for assuring safe use could be used to eliminate one tool used to slow generics.

"The idea behind the CivicaScript model is collaboration with large payers to restructure the drug production and payment systems to address systemic problems, including high generic drug prices ...

Vektor Pharma TF GmbH ("Vektor"), has finalized the formula for its novel transdermal delivery system ("TDS") for the neurologic drug Rotigotine. Vektor is now proceeding with process ...

The model caps cost-sharing at $2 for a 30-day supply of 101 generic drugs, significantly lowering patient expenses. Over 62% of beneficiaries using at least one generic drug would have ...

Dr. Janet Woodcock testified at a hearing on the review and approval process for generic prescription drugs. She also ad… Dr. Scott Gottlieb testified at a confirmation hearing on his nomination ...

The FDA said Thursday it will speed up this process by providing better advice to generic manufacturers on how to file a drug application that will be approved on the first try. Currently ...